ChitogenX Inc. (CSE: CHGX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Dec 2, 2024, 9:30 AM EST
-95.00%
Market Cap 415.65K
Revenue (ttm) n/a
Net Income (ttm) -1.73M
Shares Out 83.13M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 70,000
Open 0.0050
Previous Close 0.0050
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.1050
Beta -0.04
Analysts n/a
Price Target n/a
Earnings Date Dec 27, 2024

About ChitogenX

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirk... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol CHGX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.